Home Check-Ups for DMD: a new study tests if Tele-Assessments are reliable
NCT ID NCT06295718
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether doctors can accurately assess physical function and quality of life in children with Duchenne muscular dystrophy (DMD) through video calls. Twenty ambulatory patients aged 5-18 completed timed tests and questionnaires remotely. The goal was to see if tele-assessment is a valid and reliable alternative to in-person visits, which could ease the travel burden on families.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could allow DMD patients to be evaluated from home, reducing travel stress and saving time for families.
- What could go wrong
- This is a small, completed study with only 20 participants, so results may not apply to all patients. It tests assessment methods, not a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
20 people
The number who actually took part.
- Started
-
Jul 2023
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This research is a descriptive type observational study, and the population of the study will be 20 volunteer cases who were diagnosed with Duchenne Muscular Dystrophy at Istanbul University-Cerrahpaşa Faculty of Medicine Child Neurology Polyclinic and who meet the exclusion criteria. The study will be carried out at Istanbul University-Cerrahpaşa Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation.
- Ages
-
5 to 18 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being diagnosed with Duchenne muscular dystrophy * Being between the ages of 5-18 * Having ambulation skills * Having internet access and technical requirements * Having the ability to follow movement instructions * Volunteering to participate in the study Exclusion Criteria: * Having cognitive or behavioral problems that may interfere with evaluation * Having communication problems that may prevent evaluation * Having a level of contracture that may prevent evaluation * Having a systemic disease that may prevent evaluation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Duchenne muscular dystrophy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
İstanbul University - Cerrahpaşa
Istanbul, Istanbul, 34758, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new dosing schedule tame steroid side effects in duchenne?
- Can a daily supplement ease the toll of duchenne muscular dystrophy?
- Can a lower steroid dose preserve strength in young boys with DMD?
- Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.
- Can a massive patient database unlock new treatments for muscular dystrophy?
- Umbilical cord stem cells aim to slow muscle loss in duchenne boys